| 摘要 |
<p>The present invention relates to a novel synergistic formulation for tumor growth inhibition. More particularly it relates to a novel synergistic formulation comprising therapeutic effective amount of sorafenib hydroxyethylate with vitamin K2 and Trans chalone for tumor growth inhibition in hepatocellular carcinoma. The present method for the preparation of novel synergistic formulation is simple, cost effective and user-friendly.</p> |
